A randomised, placebo-controlled trial of anti–interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease
Crossref DOI link: https://doi.org/10.1186/s12931-017-0633-7
Published Online: 2017-08-09
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Calverley, Peter M. A.
Sethi, Sanjay
Dawson, Michelle
Ward, Christine K.
Finch, Donna K.
Penney, Mark
Newbold, Paul
van der Merwe, René
Funding for this research was provided by:
MedImmune